Actively Recruiting
Inflammatory Bowel Disease Cohort in Nantes
Led by Nantes University Hospital · Updated on 2025-02-10
360
Participants Needed
3
Research Sites
312 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The CELESTE cohort will be a three-center prospective cohort associated with the creation of a biobank including Inflammatory Bowel Diseases (IBD) patients with active disease
CONDITIONS
Official Title
Inflammatory Bowel Disease Cohort in Nantes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients over 18 years of age
- Established diagnosis of IBD including Crohn's disease, ulcerative colitis, unclassified IBD, or refractory chronic pouchitis
- Active disease requiring surgery or endoscopy at diagnosis or before starting new therapy
- Written consent given to participate and to store biological samples for research
You will not qualify if you...
- Patients who refuse to participate in the study
- Patients with inactive (quiescent) chronic inflammatory bowel disease at inclusion
- Patients with contraindications to general anesthesia
- Vulnerable patients under court protection, curatorship, or guardianship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
CHU de Nantes
Nantes, France
Actively Recruiting
2
Clinique Jules Verne
Nantes, France
Not Yet Recruiting
3
Hopital Privé du Confluent
Nantes, France
Not Yet Recruiting
Research Team
C
Catherine Le Berre, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here